The transgenic construct contains a human AML1-ETO fusion protein sequence (coding for the translocation t(8;21) associated with acute myeloid leukemia (AML)) under the transcriptional control of the tetracycline transactivator responsive promoter (tetO). Inducible expression of AML1-ETO is observed in Northern and Western blot analysis. (J:64482)